Abstract
Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.
Original language | English |
---|---|
Journal | Clinical and Experimental Rheumatology |
Volume | 39 |
Issue number | 3 |
State | Published - 1 Jan 2021 |
Keywords
- Chronic pain
- Diagnosis
- Expert opinion
- Fibromyalgia
- Quality of life
- Treatment
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology